.Invite to this week's Chutes & Ladders, our roundup of considerable management hirings, shooting...
.Complying with an inadequate showing for Lykos Rehabs' MDMA applicant for trauma at a current FDA a...
.AN2 Therapeutics is actually reassessing its company in reaction to uninspired midphase information...
.Merck & Co. is actually paying $700 thousand beforehand to test Amgen in a blood cancer market. ...
.Along With Gilead Sciences about to an FDA choice for its liver health condition medication seladel...
.CEO David Ricks may observe the providers putting together outdoors tents at basecamp behind Eli Li...
.Bed Liquidators has actually transformed Entero Therapies white as a slab. The lender got Entero to...
.Exelixis is giving up on its own cells element (TF)- targeting antibody-drug conjugate after wrappi...
.Three weeks after Roche's Genentech device walked away from an SHP2 prevention contract, Relay Reha...
.Stoke Therapies' Dravet syndrome medicine has been freed from a partial grip, removing the techniqu...